Cancer treatments in children have improved such that many children live to adulthood. However, certain treatments may pose a risk for harmful effects on the heart. How often adults who were exposed to such treatments have evidence of harm to the heart is unknown.
What is the problem and what is known about it so far?
Cancer treatments in children have improved such that many children live to adulthood. However, certain treatments may pose a risk for harmful effects on the heart. How often adults who were exposed to such treatments have evidence of harm to the heart is unknown.
Why did the researchers do this particular study? To find out how often adults have heart problems after receiving certain cancer treatments during their childhood.
Who was studied?
1853 adult survivors of childhood cancer.
How was the study done?
The researchers asked people aged 18 years or older who received cancer treatment as children to participate in an ongoing study to evaluate many health issues. Those who agreed and had been treated during childhood with anthracycline chemotherapy or radiation that passed through the heart were asked to attend an evaluation. At this evaluation, participants answered questions about symptoms and had tests to determine whether they had any heart abnormalities.
What did the researchers find?
On average, the participants were aged 31 years at the time of the study evaluation and received treatment for childhood cancer up to 24 years earlier. A substantial number of the participants had evidence of heart problems. These included problems with the heart's muscle (called cardiomyopathy) in approximately 7% of the participants, its electrical conduction system in almost 5%, its blood supply (called coronary artery disease) in nearly 4%, and its valves in roughly 28%. Most participants had no symptoms from these abnormalities, although participants with heart abnormalities were more likely to be unable to perform as much exercise as expected when tested.
What were the limitations of the study?
Not all adults who were exposed to the treatments participated in the study, which might have affected how often heart abnormalities were found. In addition, the study did not include adults who had been exposed to other types of cancer treatments, so it is not known how often these heart problems may occur after other treatments. This study did not follow the participants to see whether they developed problems from the abnormalities identified; therefore, it is not yet clear whether screening for heart problems in these people is beneficial.
What are the implications of the study?
Adults who were treated as children with anthracycline chemotherapy or radiation that went through the heart seem to have heart problems more frequently than normal. More studies are needed to determine whether actively looking for these abnormalities will prevent problems. 
